Fair Value Measurements (Narrative) (Detail) (USD $) In Thousands, unless otherwise specified								3 Months Ended			1 Months Ended
	Sep. 30, 2014	Sep. 30, 2014 Rising Pharmaceuticals Inc.	Jun. 30, 2014 Rising Pharmaceuticals Inc.	Sep. 30, 2014 France Company	Jun. 30, 2014 France Company	Sep. 30, 2014 PACK Pharmaceuticals, LLC	Jun. 30, 2014 PACK Pharmaceuticals, LLC	Sep. 30, 2014 Foreign exchange contract	Sep. 30, 2013 Foreign exchange contract	Sep. 30, 2014 Interest rate swap	Apr. 30, 2014 Interest rate swap Cash flow hedging	Mar. 31, 2011 Interest rate swap Cash flow hedging	Sep. 30, 2014 Interest rate swap Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount								$ 40,534		$ 7,250	$ 25,750	$ 20,000	$ 26,750
Unrealized gains (losses) on hedging activities								(806)	381
Derivative, interest rate											1.63%	1.91%
Derivative, expiration date											Apr. 30, 2019	Dec. 31, 2015
Unrealized loss recorded in accumulated other comprehensive income	(185)
Contingent consideration at fair value		$ 5,784	$ 5,694	$ 392	$ 413	$ 3,905	$ 3,797